
Please try another search
Walvax Biotechnology Co., Ltd., engages in the research and development, manufacture, and distribution of vaccines in China. Its vaccine portfolio includes recombinant human papillomavirus bivalent, 13-valent pneumococcal polysaccharide conjugate, 23-valent pneumococcal polysaccharide, group ACYW135 meningococcal polysaccharide, group A and C meningococcal polysaccharide, group A and group C meningococcal conjugate, and haemophilus influenzae type b conjugate vaccines, as well as diphtheria, tetanus and acellular pertussis combined vaccine. The company was founded in 2001 and is headquartered in Kunming, China.
Name | Age | Since | Title |
---|---|---|---|
Yunchun Li | 63 | 2009 | Chairman |
Yongwu Fan | 53 | 2020 | Non-Independent Director |
Shiqing Ding | 63 | 2020 | Chairwoman of the Supervisory Board |
Jinyu Zhu | 58 | 2022 | Independent Director |
Jianmei Zhao | 56 | 2020 | Independent Director |
Shaozhong Dong | 57 | 2022 | Vice Chairman & VP |
Geng Yun | 28 | 2022 | Employee Supervisor |
Ganghong Sun | 56 | 2022 | Independent Director |
Wei Yao | 53 | 2016 | President & Director |
Ting Yan | 38 | 2021 | Director |
Lingbing Zeng | 68 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review